Texas A&M Canine Clinical Trial Reveals STING Agonist May Be Viable Treatment for Human Glioblastoma
August 26, 2021
August 26, 2021
COLLEGE STATION, Texas, Aug. 26 (TNSJou) -- Texas A&M University's College of Veterinary Medicine and Biomedical Sciences issued the following news release on Aug. 25, 2021:
A team of researchers at Texas A&M University, Northwestern University, and ImmunoGenesis have discovered a treatment for glioblastoma that has promising implications for the human version of the aggressive cancer form that grows in the brain.
Published today in Clinical Cancer Research . . .
A team of researchers at Texas A&M University, Northwestern University, and ImmunoGenesis have discovered a treatment for glioblastoma that has promising implications for the human version of the aggressive cancer form that grows in the brain.
Published today in Clinical Cancer Research . . .